Fig. 6From: Erythropoietin does not activate erythropoietin receptor signaling or lipolytic pathways in human subcutaneous white adipose tissue in vivoHaematoxylin/Eosin staining of WAT after prolonged ESA treatment. Haematoxylin/eosin staining of selected WAT samples from 2 subjects treated with placebo and 2 with ESA for 10 weeksBack to article page